NIH R01 · 2024
Cannabis effects on physical and mental health in medical cannabis patients
ABSTRACT With increasing legalization of medicinal cannabis, there is an urgent need to identify patients at-risk for cannabis use disorder (CUD), which can occur as an unintended adverse effect of using medicinal cannabis. A national survey indicated that 11% who used medicinal cannabis met criteria for a past year DSM-IV CUD. However, DSM-based CUD diagnosis has limitations when applied to medicinal cannabis (MC). Specifically, many MC patients might report tolerance and withdrawal due to frequent MC use, but not show a pathological pattern of cannabis use (e.g., impaired control over use). To improve identification of MC patients who show a pathological pattern of use, we extend DSM-5’s…
From the public funding record at NIH RePORTER. Describes the funded project, not the reviews below.